(Total Views: 443)
Posted On: 10/09/2024 8:13:23 PM
Post# of 148870
Wow, worked on Resmetirom ----
“Throughout the third quarter, the Madrigal team continued to progress MAESTRO-NASH, the pivotal serial liver biopsy study and a key component of the Phase 3 program for resmetirom for patients with non-alcoholic steatohepatitis, NASH."
https://ir.madrigalpharma.com/news-releases/n...nd-reports
____
Posting on the fly as I just now found the connects.
Post n go...lol
He presented on the "key component".
Madgril, just make the check to:
Cytodyn, inc.
“Throughout the third quarter, the Madrigal team continued to progress MAESTRO-NASH, the pivotal serial liver biopsy study and a key component of the Phase 3 program for resmetirom for patients with non-alcoholic steatohepatitis, NASH."
https://ir.madrigalpharma.com/news-releases/n...nd-reports
____
Posting on the fly as I just now found the connects.
Post n go...lol
He presented on the "key component".
Madgril, just make the check to:
Cytodyn, inc.
(1)
(0)Scroll down for more posts ▼
